Cost of HPV vaccine is prohibitive in developing world, Nobel winner says

Silversides, Ann
December 2009
CMAJ: Canadian Medical Association Journal;12/8/2009, Vol. 181 Issue 12, pE288
Academic Journal
The article discusses the statement of Nobel Prize winner Dr. Harald Zur Hausen that the cost human papilloma virus (HPV) vaccine must be brought down in order to improve its access in the developing world. He emphasizes on the need to make the vaccine affordable in those parts of the world who need it most in which the incidence is the same in the developed and developing world. It states that certain HPV viruses lead to cervical cancer which is the second most frequent cancer in women.


Related Articles

  • Nobel laureate calls for HPV vaccine for boys. Innis, Andrew // Xtra (Toronto);11/6/2008, Issue 627, p11 

    The article reports on the call of Harald zur Hausen, the Nobel Prize winning pioneer of human papilloma virus (HPV) research, for the vaccination of boys against the virus.

  • Who Should and Who Should Not Be Vaccinated Against Human Papillomavirus Infection? Paavonen, Jorma // European Journal of Oncological Medicine;2010, Vol. 2 Issue 2, p3 

    Approximately 30 years ago Dr. Harald zur Hausen and others from the German Cancer Research Center in Heidelberg, published the landmark papers of the link between high risk human papillomavirus (HPV) types 16/18 and cervical cancer. This discovery of cervical cancer led to Blackburn, Greider...

  • The paediatric story of human papillomavirus. MAMMAS, IOANNIS N.; SOURVINOS, GEORGE; SPANDIDOS, DEMETRIOS A. // Oncology Letters;2014, Vol. 8 Issue 2, p502 

    Human papillomavirus (HPV) is composed of a particularly heterogeneous family of DNA viruses, which has gained much attention in recent years due to the discoveries of Professor Harald zur Hausen, who first identified a connection between HPV and cervical cancer. Professor Harald zur Hausen, the...

  • From the editors.  // Nature Reviews Cancer;Nov2008, Vol. 8 Issue 11, p825 

    The article announces that Harald zur Hausen was awarded the 2008 Nobel Prize in Physiology or Medicine for his work on human papillomavirus (HPV) infection.

  • It's time for more public schools to join the fight against cervical cancer. Wellisch, Lawren D.; Brown, Benjamin P. // Infectious Diseases in Children;May2014, Vol. 27 Issue 5, p7 

    The article presents author's views regarding advantages of human papilloma virus (HPV) vaccine in reducing rate of cervical cancer.

  • Betting Swiss gold on HPV vaccination.  // PharmacoEconomics & Outcomes News;5/31/2008, Issue 554, p7 

    The article reports that researchers who used a U.S. Markov model have concluded that adding human papillomavirus (HPV) vaccination to the current cervical cancer screening programme has the potential to be cost effective in Switzerland.

  • Does the HPV Vaccine Prevent Cervical Cancer? AUTHOR REPLY. LIN, KENNETH W. // American Family Physician;7/1/2014, Vol. 90 Issue 1, p8 

    A response from the author of the article "Cervical Cancer" in the June 15, 2012 issue is presented.

  • Who is Cancer Charlie, and how do we stop him?  // Contraceptive Technology Update;Sep2009, Vol. 30 Issue 9, p104 

    The article focuses on the safety issues and use of the vaccine Gardasil to prevent human papillamovirus (HPV) which causes cervical cancer to women.

  • Moving forward with HPV vaccination. Steinke, Leah // Infectious Disease News;Sep2013, Vol. 26 Issue 9, p24 

    The article reports on the greater need for Human papillomavirus (HPV) vaccination in the U.S. after it was found that HPV, particularly HPV-16 and HPV-18, was responsible for causing about 70 percent of all cervical cancers.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics